Astellas Transfers Three European Plants to Temmler Group
Astellas Pharma Inc. announced that Temmler Group and Astellas have reached an agreement and concluded a contract providing for the transfer by Astellas of bulk assets comprising the Munich Plant and Klinge Ireland Plant of Astellas Deutschland GmbH, and all stocks of Produzioni Farmaceutiche Carugate S.r.l, to Temmler Group.
Astellas has previously declared in its mid-term 5-year management plan, ending in FY2010 (fiscal year ending March 2011), that the number of production sites will be reduced from the current 18 ( 9 in Japan and 9 overseas) to around 10 by FY2010 to achieve an optimal production system. This transfer of three plants has been effected in order to carry out this mid-term 5-year management plan.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.